Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07075159 · ClinicalTrials.gov registry record · NA
Hydrocolloid Dressings for Oculofacial Plastic and Reconstructive Wound Healing
A NA study of Wound Healing and Mohs Micrographic Surgery, sponsored by Janice Hernandez, MD.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT07075159: Recruiting NA study of Wound Healing and Mohs Micrographic Surgery, sponsored by Janice Hernandez, MD.
NCT07075159 is a NA study of Wound Healing and Mohs Micrographic Surgery that is actively recruiting participants, run by Janice Hernandez, MD. The registered enrollment target is 20 participants, below the 56-participant average among 11 other Wound Healing trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07075159, a NA study of Wound Healing and Mohs Micrographic Surgery, is actively recruiting participants, sponsored by Janice Hernandez, MD.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to explore the use of a hydrocolloid dressing (DuoDERM EXTRA THIN) as an alternative to the current standard of care. The dressing would be applied immediately after surgery and removed at a post-operative week 1 appointment. The dressing would eliminate the need for antibiotic ointment application and reduce the burden of post-operative care on the patient.
Primary Outcome
YES/NO type question if wound dehiscence is present after removal of the patch
Conditions Studied
Interventions
- DEVICE Hydrocolloid Wound Dressing
Study Locations (1)
Kentucky
- University of Kentucky - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-02-28 |
| Est. Completion | 2026-09-01 |
| Phase | NA |
What NCT07075159 shows while recruiting
NCT07075159 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 56-participant average among 11 other Wound Healing trials with a reported enrollment target (64% lower).
The record links to 3 conditions, with Wound Healing appearing as the primary indexed condition, and to 1 intervention - of which Hydrocolloid Wound Dressing is the first listed.
NCT07075159 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT07075159 about?
NCT07075159 is a clinical study titled "Hydrocolloid Dressings for Oculofacial Plastic and Reconstructive Wound Healing". This study aims to explore the use of a hydrocolloid dressing (DuoDERM EXTRA THIN) as an alternative to the current standard of care. The dressing would be applied immediately after surgery and removed at a post-operative week 1 appointment. The dressing would eliminate the need for antibiotic ointm...
What is the current status of trial NCT07075159?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-02-28. Estimated completion is 2026-09-01.
What conditions does trial NCT07075159 study?
This clinical trial studies the following conditions: Wound Healing, Mohs Micrographic Surgery, Oculofacial Reconstruction.
What interventions are being tested in trial NCT07075159?
The interventions under investigation include: Hydrocolloid Wound Dressing (DEVICE).
Who is sponsoring clinical trial NCT07075159?
This trial is sponsored by Janice Hernandez, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07075159 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wound Healing
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07075159's enrollment target sits among peer trials
20 11th of 11 higher than 1 of 11 other Wound Healing trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Wound Healing trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Silk Bioprotein as a Wound Dressing for Double-Incision Mastectomy
RECRUITING · NA
-
NPWT Reduction Mammaplasty
RECRUITING · NA
-
Assessment Of Infrared Photobiotherapy for Improved Wound Healing
COMPLETED · NA
-
Clinical Study Evaluating Wound Closure With Endoform™ and Symphony™
COMPLETED · NA
-
Determinants of Bone Dimensional Changes After Extraction and Alveolar Ridge Preservation
RECRUITING
-
Evaluating rhPDGF-BB-Enhanced Wound Matrix for Head and Neck Reconstruction
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI